Coronavirus (COVID-19)
Learn more
January 06, 2017
Location: Hartford Hospital's Institute of Living
The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 7-17 years of age for a double-blind, clinical trial using Vilazodone for the treatment of pediatric and adolescent major depressive disorder. After completion of the 8-week study, subjects are eligible for a 6-month open-label trial of Vilazodone. For more information about this trial, please contact: Dr. Salma Malik Phone: 860.545.7502 Email: clinical.trials@hhchealth.org
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.